During the past decade, Dongguk University Ilsan Hospital conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 6 clinical trials were completed, i.e. on average, 35.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dongguk University Ilsan Hospital" #1 sponsor was "DongGuk University" with 9 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Gilead Sciences" with 2 trials sponsored and "Seoul National University Hospital" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dongguk University Ilsan Hospital" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "Daiichi Sankyo Korea Co., Ltd." with 1 trials as a collaborator, "Dong-A ST Co., Ltd." with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Ministry of Food and Drug Safety, Korea" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Dongguk University Ilsan Hospital" are "Diabetes Mellitus, Type 2" (3 trials), "Hypertension" (3 trials), "Ambulatory Blood Pressure" (2 trials), "Atopic Dermatitis" (2 trials) and "Hepatitis C Virus" (2 trials). Many other conditions were trialed in "Dongguk University Ilsan Hospital" in a lesser frequency.

Most popular intervention types in "Dongguk University Ilsan Hospital" are "Drug" (13 trials) and "Behavioral" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Baricitinib" (2 trials), "BI 456906" (1 trials), "CKD-828 40/2.5mg" (1 trials) and "CKD-828 40/5mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dongguk University Ilsan Hospital" are 18 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Dongguk University Ilsan Hospital". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Dongguk University Ilsan Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Dongguk University Ilsan Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".